Recent News

• 03.25.2026 - Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
• 03.19.2026 - Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update
• 02.23.2026 - Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02

Recent Filings

• 03.25.2026 - EX-99.1 EX-99.1
• 03.25.2026 - 8-K Current report
• 03.25.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.19.2026 - EX-99.1 EX-99.1
• 03.19.2026 - 8-K Current report
• 03.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities